NL-OMON43165已完成不适用
Effect of administration of single dose Histidine-Tryptophane-Ketoglutarate (HTK) cardioplegia solution on serum sodium concentration, osmolarity and acid-base balance. - Effect of HTK on serum sodium concentration, osmolarity.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* patients undergoing non emergency cardiothoracic surgery where HTK solution or St Thomas' cardioplegia solution will be used for myocardial protection
- •* Older than 18 years
排除标准
- •* Emergency procedures
- •* Younger than 18 years
- •* Allergy to HTK or St Thomas' cardioplegie
- •* Serum sodium abnormalities before surgery
研究者
相似试验
已完成
不适用
Investigation on the effectiveness of histidine copper treatment of Menkes disease patientsMenkes diseaseJPRN-UMIN000030626Hamamatsu University School of Medicine2
已完成
不适用
Effect of chewing and histidine intake for prevention and improvement of metabolic syndromeJPRN-UMIN000029356The university of shizuoka30
招募中
不适用
Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.Appetite suppression on stimulant medication. This is the presumed reason for the weight loss that usually occurs when children with attention deficit hyperactivity disorder (ADHD) are treated with dexamphetamine or methylphenidate.Healthy adult volunteers.Mental Health - Other mental health disordersACTRN12607000138482Chief investigator Dr Alison Poulton12
尚未招募
4 期
The effect of Histidine -Tryptophan-Ketoglutarate cardioplegia alone or combined with preoperative infusion of levosimendan on vasoactive inotropic score in patients with poor cardiac function undergoing coronary artery bypass graftingPACTR202207785952318Maha Elkotb102
进行中（未招募）
1 期
A study to evaluate safety and efficiency of treatment with histamine and interleukin-2 in chronic myelomonocytic leukemia (CMML)Chronic myelomonocytic leukemiaEUCTR2014-004874-41-SEordic MDS study group15